International research partnerships

International collaborations help our investments to go further. Learn more about our international partnerships and how they influence the dementia research landscape.

Our collaborations support the exchange of knowledge, influencing the dementia landscape worldwide and ensuring UK researchers benefit from international initiatives and funding.

Joint Programme - Neurodegenerative Diseases 

Alzheimer’s Society alongside other UK funders have united with 15 countries across Europe, Australia and Canada to support international research collaborations into diseases of the brain, including those which cause dementia. 

The latest Joint Programme – Neurodegenerative Disease (JPND) will award €17.5 million (£15.75 million) over the next three years.

The programme aims to bring together expertise of researchers around the world to speed up progress towards new treatments and tackle challenges. 

What research is being funded?

Alzheimer’s Society, along with Department of Health and Social Care England, Health and Care Research Wales and Health and Social Care Northern Ireland, has committed £2.15 million to the programme from the UK. UK research teams are involved in eight of the 10 projects awarded funding.

Joint Programme – Neurodegenerative Disease (JPND)

Discover more about the UK highlights from JPND

Read more

Global Brain Health Institute 

Alzheimer’s Society has united with the Global Brain Health Institute and Alzheimer’s Association US to support emerging leaders in health and dementia through a unique funding programme – the Pilot Awards for Global Health Leaders. 

The programme supports small-scale pilot projects to advance skills, knowledge, activities and efforts to reduce the impact of dementia and improve brain health around the world. 

What research is being funded?

21 pilot projects have been awarded spanning 10 countries including Brazil, Colombia, Cuba, Greece, Ireland, Israel, Mexico, Turkey, UK and USA. The total funding awarded is over $500,000 (over £390,000). 

Alzheimer’s Society is a partner in all the research awards but specifically funds two UK based projects.

Investigating burdensome end of life care people with advanced dementia

  • Lead Investigator:  Dr Elizabeth Dzeng
  • Institution: King’s College London, University of California and France.


Identifying people with dementia who may benefit from palliative care

  • Lead Investigator: Corrina Grimes
  • Institution: Global Brain Health Institute, GP practices across Northern Ireland
Think this page could be useful to someone? Share it:

Further reading